← Back to Search

1 for Type 2 Diabetes

N/A
Waitlist Available
Led By Stephen F. Figoni
Research Sponsored by US Department of Veterans Affairs
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

The purposes of this pilot project are to (a) determine changes in calf muscle blood flow and energy supply resulting from calf muscle exercise, and (b) to determine changes in these variables resulting from exercise training (walking and calf muscle exercise). This is a pilot study to prepare for a larger project in the future. Exercise and exercise training should increase blood flow and energy supply to the calf muscles.

Eligible Conditions
  • Type 2 Diabetes
  • Intermittent Claudication

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment2 Interventions
treadmill walking and calf exercise
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Physical walking
2005
N/A
~50
Physical exercise
2016
Completed Phase 4
~2080

Find a Location

Who is running the clinical trial?

US Department of Veterans AffairsLead Sponsor
872 Previous Clinical Trials
497,939 Total Patients Enrolled
Stephen F. FigoniPrincipal InvestigatorVA Greater Los Angeles Healthcare System, West LA
~2 spots leftby Sep 2025